HEALTH Low lung-cancer awareness in Connacht
A report highlights the poor state of lung-cancer knowledge and the importance of early detection of the disease.
Low lung-cancer awareness in Connacht
A new study by Empathy Research has found that almost one in five people living in Connacht are unable to name even one symptom of lung cancer, while a further 64 per cent are unaware that lung cancer is the leading cause of cancer-related death in Ireland.
More than 1,700 Irish people are diagnosed with the disease annually and survival rates are low, with almost 90 per cent of all patients dying within five years of diagnosis. One of the primary causes for the high mortality rate is the relatively late stage at which the disease is diagnosed.
Symptoms of lung cancer may include one or several of the following: a persistent cough that lasts more than two to three weeks, constant chest or shoulder pain, coughing up blood, shortness of breath, persistent chest infections, unexplained fatigue and unexplained weight loss. Symptoms may vary from person to person. Early diagnosis is key in surviving the deadly disease. However, despite this, a recent pan-European report (Benchmarking Report of Lung Cancer in Selected European Countries) showed that only 12 per cent lung cancer patients in Ireland were detected at the early stages of the disease.
Commenting, Norma Cronin, Health Promotion Manager, Irish Cancer Society, said: “The results of this research show a clear lack of knowledge among the public about the disease … We need to ensure that people are aware of the signs and symptoms of lung cancer, and visit their GP without delay should they feel they might be at risk from this illness.”
Dr Ross Morgan, Consultant Respiratory Physician at Beaumont Hospital and member of the Irish Thoracic Society’s Lung Cancer Group, added: “It is imperative that anyone who recognises the signs and symptoms of lung cancer visits their GP urgently, as lung cancer survival is very much dependent on early diagnosis. Currently, less than 15 per cent of Irish patients are having surgical treatment for lung cancer, despite the fact that surgery represents the best chance for a cure. This low figure reflects the fact that the cancer is often at a relatively advanced stage by the time patients present with symptoms.”
Dr Morgan also explained that new physician guidelines were launched at the end of 2009, provide physicians with updated information relating to the diagnosis and treatment.’ The introduction of new treatments raises the prospect of improving survival rates. However, a recent finding from the Euro Health Consumer Index 2009 found that Ireland ranked 20th of 33 countries in deploying new drugs, with a score of 44 out of a European average of 100, judged on per capita use of a basket of 21 new cancer drugs.